Related Experiment Video
Updated: Sep 16, 2026

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
Published on: November 28, 2016
[LDL apheresis in the treatment of hyperlipoproteinemia]
1Kure National Hospital, Department of Internal Medicine.
Insights
LDL-apheresis effectively reduces LDL cholesterol in Familial hypercholesterolemia (FH) patients. This treatment shows evidence of atherosclerosis regression with no significant long-term side effects, offering future potential for coronary heart disease management.
Area of Science:
- Cardiology
- Biochemistry
- Medical Technology
Context:
- Familial hypercholesterolemia (FH) is a genetic disorder causing high LDL cholesterol.
- Direct LDL removal techniques are crucial for managing FH.
- Selective LDL-apheresis using dextran sulfate cellulose columns is utilized in Japan for FH treatment.
Purpose:
- To review the effectiveness of LDL-apheresis in FH patients.
- To present evidence of atherosclerosis regression due to LDL-apheresis.
- To discuss the future role of LDL-apheresis in coronary heart disease treatment.
Summary:
- LDL-apheresis, specifically using dextran sulfate cellulose columns, is an established treatment for both homozygous and heterozygous FH patients in Japan.
- The review highlights significant evidence demonstrating the regression of atherosclerosis in patients undergoing this therapy.
- Long-term treatment with LDL-apheresis has not resulted in any notable adverse side effects.
Impact:
- LDL-apheresis demonstrates significant potential as a therapeutic strategy for managing FH.
- The technique shows promise in mitigating atherosclerosis progression, a key factor in coronary heart disease.
- Its safety profile supports its consideration for long-term management of cardiovascular risk in FH patients.
Abstract:
In order to the reduce the LDL level of Familial hypercholesterolemia (FH), direct LDL removal techniques have been used in several laboratories. In Japan, selective LDL-apheresis by dextran sulfate cellulose column have been developed and is used in treatment of homo- and heterozygous FH patients. In this paper, I reviewed the effectiveness of LDL-apheresis treatment in FH patients with many evidences of regression of atherosclerosis and discussed the potential role of this technique in the future treatment for coronary heart disease. No significant side effect for long term treatment is not experienced.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Inhibitors of Viral Protein Synthesis

